Multiple ETS Factors Participate in the Transcriptional Control of <i>TERT</i> Mutant Promoter in Thyroid Cancers.

Cancers (Basel) · 2022 · PMC8774187 · PMID 35053525

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

To further study the effects of these factors in an extended panel of cell lines, we selected the aforementioned seven ETS proteins, along with EHF and ETS2, which showed marginally significant reductions in TERT expression, and GABPA, which had been reported in other cancer lineages.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.